Crossmark

Iron Modulation Enhances Anticancer Activity of Atorvastatin in SH-SY5Y Neuroblastoma Cells

Crossref DOI link: https://doi.org/10.1007/s44411-025-00359-3

Published Online: 2025-10-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Altunkaynak, Hande Ozge https://orcid.org/0000-0002-4547-7756
Elci, Pinar https://orcid.org/0000-0003-1007-9456
Cetinkaya, Serdar https://orcid.org/0000-0001-9469-5066
Esim, Ozgur https://orcid.org/0000-0002-6402-156X
Yucel, Cigdem https://orcid.org/0000-0003-2647-440X
Kose-Ozkan, Cansel https://orcid.org/0000-0002-4340-7279
Erdem, Onur https://orcid.org/0000-0002-5849-3552
Ozkan, Yalcın https://orcid.org/0000-0001-5163-6867
License Information

Text and Data Mining valid from 2025-10-03

Version of Record valid from 2025-10-03
More Information

Article History

Received: 9 July 2025

Revised: 8 September 2025

Accepted: 17 September 2025

First Online: 3 October 2025

Declarations

:

: The authors declare no competing interests.

: Not applicable.